致幻剂治疗精神障碍:解读与转化现有证据及未来研究指引
过去十年,致幻剂作为难治性精神障碍的潜在疗法备受关注。短期对照试验数据提示,某些致幻剂对重性抑郁障碍、难治性抑郁和创伤后应激障碍有效且安全,初步证据也支持其对其他精神障碍有效。然而,研究结果的可解释性和可转化性存在担忧,本文旨在回顾影响推断的方法学问题并为未来研究提供指引。
要点
- 短期对照试验数据提示某些致幻剂对重性抑郁障碍、难治性抑郁和创伤后应激障碍有效且安全。
- 初步证据支持致幻剂对其他精神障碍(如烟草和酒精使用障碍)有效。
- 致幻剂相关短期和长期安全性、滥用倾向及「旅程」和心理支持的必要性等特征尚不充分。
核心结论
- 短期对照试验数据提示某些致幻剂对重性抑郁障碍、难治性抑郁和创伤后应激障碍有效且安全,初步证据支持对其他精神障碍有效。
- 致幻剂相关短期和长期安全性、滥用倾向及致幻「旅程」和心理支持的必要性等特征尚不充分。
- 本文旨在回顾影响推断的方法学问题并为未来致幻剂治疗的研究和开发提供指引。
研究设计与样本
- 本文为概述性综述,回顾影响致幻剂研究推断与解读的方法学问题,并为未来研究和临床实施提供指引。
主要发现
- 短期对照试验数据提示某些致幻剂对重性抑郁障碍、难治性抑郁和创伤后应激障碍有效且安全。
- 初步证据支持致幻剂对其他精神障碍(如烟草和酒精使用障碍)有效。
- 致幻剂相关短期和长期安全性、滥用倾向及致幻「旅程」和心理支持的必要性等特征尚不充分。
局限性
- 致幻剂相关短期和长期安全性、滥用倾向及致幻「旅程」和心理支持的必要性等特征尚不充分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During the past decade, there has been extraordinary public, media, and medical research interest in psychedelics as promising therapeutics for difficult-to-treat psychiatric disorders. Short-term controlled trial data suggest that certain psychedelics are effective and safe in the treatment of major depressive disorder, treatment-resistant depression, and posttraumatic stress disorder. Preliminary evidence also supports efficacy in other psychiatric disorders (e.g., tobacco and alcohol use disorders). Notwithstanding the interest and promise of psychedelics, concerns have arisen with respect to the interpretability and translatability of study results. For example, aspects related to short- and long-term safety, abuse liability, and the essentiality of the psychedelic "trip" and psychological support are, inter alia, insufficiently characterized with psychedelic agents. The overarching aims in this overview are 1) to review methodological aspects that affect inferences and interpretation of extant psychedelic studies in psychiatric disorders, and 2) to provide guidance for future research and development of psychedelic treatment in psychiatry, critical to study interpretation and clinical implementation.
引用
- McIntyre RS, Kwan ATH, Mansur RB, et al. Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research. Am J Psychiatry. 2025. PMID: 39741444. doi:10.1176/appi.ajp.20230902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。